The Joint Corp.

NasdaqCM JYNT

The Joint Corp. Price to Sales Ratio (P/S) on January 14, 2025: 1.27

The Joint Corp. Price to Sales Ratio (P/S) is 1.27 on January 14, 2025, a 11.96% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

The Joint Corp. 52-week high Price to Sales Ratio (P/S) is 2.20 on May 16, 2024, which is 73.38% above the current Price to Sales Ratio (P/S).
The Joint Corp. 52-week low Price to Sales Ratio (P/S) is 1.13 on January 16, 2024, which is -10.69% below the current Price to Sales Ratio (P/S).
The Joint Corp. average Price to Sales Ratio (P/S) for the last 52 weeks is 1.51.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

NasdaqCM: JYNT

The Joint Corp.

CEO	Mr. Sanjiv Razdan
IPO Date	Nov. 11, 2014
Location	United States
Headquarters	16767 North Perimeter Drive
Employees	444
Sector	Health Care
Industries Hospitals & Clinics

Description

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

Key trends

Past 5 years